Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome

Clinical trial NCT04952155 · UNKNOWN

Trial details

NCT number: NCT04952155
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-01-01
Primary completion: 2021-12-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.